Exogenous lactase in the treatment of oral acyclovir intolerance.
Manka
R L
RL
Department of Ophthalmology, University of Minnesota.
D000212:Acyclovir / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000284:Administration, Oral; D000328:Adult; D003967:Diarrhea / Q000139:chemically induced* / Q000188:drug therapy; D004361:Drug Tolerance; D005696:Galactosidases / Q000627:therapeutic use*; D006801:Humans; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D007787:Lactose Intolerance / Q000188:drug therapy; D008297:Male; D001616:beta-Galactosidase / Q000008:administration & dosage / Q000627:therapeutic use*
D005696:Galactosidases; D001616:beta-Galactosidase; D000212:Acyclovir